Classification and functions of enteroendocrine cells of the lower gastrointestinal tract

International Journal of Experimental Pathology

Volumn 92, Issue 4, 2011, Pages 219-231

  Gunawardene, Ashok R ^a   Corfe, Bernard M ^a   Staton, Carolyn A ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Colon; Enteroendocrine; Neuroendocrine; Rectum

Indexed keywords

CHROMOGRANIN A; GLICENTIN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; OXYNTOMODULIN; PEPTIDE YY; SEROTONIN; SEROTONIN 3 ANTAGONIST; SEROTONIN RECEPTOR; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE;

CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VACUOLE; CELLULAR DISTRIBUTION; CHROMAFFIN CELL; COLON DILATATION; COLORECTAL CARCINOMA; DIARRHEA; ENTEROENDOCRINE CELL; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE CELL; INTESTINE MUCOSA; INTRACELLULAR SIGNALING; L CELL; NEUROENDOCRINE TUMOR; NONHUMAN; OBESITY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; REVIEW; SEROTONIN RELEASE; SOMATOSTATIN CELL; TUMOR DIFFERENTIATION; VISCERAL PAIN;

ADENOCARCINOMA; COLORECTAL NEOPLASMS; DIGESTION; DISEASE PROGRESSION; ENTEROENDOCRINE CELLS; GASTROINTESTINAL DISEASES; HUMANS; LOWER GASTROINTESTINAL TRACT;

EID: 79959911030     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2011.00767.x     Document Type: Review

References (138)

1. Abdu F., Hicks G.A., Hennig G., Allen J.P., Grundy D. (2002) Somatostatin sst(2) receptors inhibit peristalsis in the rat and mouse jejunum. Am. J. Physiol. Gastrointest. Liver Physiol. 282, G624-G633.
2. Adrian T.E., Ballantyne G.H., Longo W.E. et al. (1993) Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon. Gut 34, 1219-1224.
3. Ahlman H. & Dahlstrom A. (1983) Vagal mechanisms controlling serotonin release from the gastrointestinal tract and pyloric motor function. J. Auton. Nerv. Syst. 9, 119-140.
4. Ahlman H. & Nilsson O. (2003) The gut as the largest endocrine organ in the body. Ann. Oncol. 12 (Suppl. 2), S63-S68.
5. Andrew A., Kramer B., Rawdon B.B. (1998) The origin of gut and pancreatic neuroendocrine (APUD) cells - the last word? J. Pathol. 186, 117-118.
6. Anini Y., Fu-Cheng X., Cuber J.C.C., Kervran J.C., Roze C. (1999) Comparison of the post-prandial release of peptide YY and proglucagon-derived peptides in the rat. Eur. J. Physiol. 438, 299-306.
7. Ashcroft F.M., Proks P., Smith P.A., Ammala C., Bokvist K., Rorsman P. (1994) Stimulus-secretion coupling in pancreatic beta cells. J. Cell. Biochem. 55, 54-65.
8. Ballantyne G.H. (2006) Peptide YY(1-36) and peptide YY (3-36): past I. Distribution, release and actions. Obes. Surg. 16, 651-658.
9. Bingham S.A., Day N.E., Luben R. et al. (2003) Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 361, 1496-1501.
10. Bjornssen E.S., Chen W.D., Hooper F., Woods M.L., Owyang C., Hasler W. (2002) Impaired gastrocolonic response and peristaltic reflex in slow transit constipation: role of 5-HT3 pathways. Am. J. Physiol. 283, G400-G407.
11. Blum A.M., Metwali A., Mathew R.C., Cook M.G., Elliott D., Weinstock J.V. (1992) Granuloma T lymphocytes in murine schistosomiasis mansoni have somatostatin receptors and respond to somatostatin with decreased IFN-gamma secretion. J. Immunol. 149, 3621.
12. Bocci G., Culler M.D., Fioravanti A. et al. (2007) In vitro antiangiogenic activity of selective somatostatin subtype-1 receptor agonists. Eur. J. Clin. Invest. 37, 700-708.
13. Borges R., Diaz-Vera J., Dominguez N., Arnau M.R., Machado J.D. (2010) Chromogranins as regulators of exocytosis. J. Neurochem. 114, 335-343.
14. Borman R.A. & Burleigh D.E. (1997) Heterogeneity of 5-HT receptors mediating secretion in the human intestine. Ann. N Y Acad. Sci. 812, 224-225.
15. Bottcher G., Sjolund K., Ekblad R., Hakanson R., Schwartz T.W., Sundler F. (1984) Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut. Regul. Pept. 8, 261-266.
16. Braun T., Voland P., Kunz L., Prinz C., Gratzl M. (2007) Enterochromaffin cells of the human gut: sensors for spices and odorants. Gastroenterology 132, 1890-1901.
17. Buffa R., Capella C., Fontana P., Usellini L., Solcia E. (1978) Types of endocrine cells in the human colon and rectum. Cell Tissue Res. 192, 227-240.
18. Cani P.D., Hoste S., Guiot Y., Delzenne N.M. (2007) Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br. J. Nutr. 98, 32-37.
19. Capella C., Solcia E., Frigerio B., Buffa R. (1976) Endocrine cells of the human intestine. An ultrastructural study. In: Endocrine Gut and Pancreas, pp. 42-59 (ed. T. Fujita ), Amsterdam: Elsevier.
20. Chen J.J., Li Z., Pan H. et al. (2001) Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: abnormal intestinal motility and the expression of cation transporters. J. Neurosci. 21, 6348-6361.
21. Chiba M., Sanada Y., Kawano S. et al. (2007) Glicentin inhibits internalization of enteric bacteria by cultured INT-407 enterocytes. Pediatr. Surg. Int. 23, 551-554.
22. Chisholm C. & Greenberg G.R. (2000) Somatostatin receptor subtype-5 mediates inhibition of peptide YY secretion from rat intestinal cultures. Am. J. Physiol. Gastrointest. Liver Physiol. 279, G983-G989.
23. Cho Y.M. & Kieffer T.J. (2010). K-cells and glucose-dependent insulinoptropic polypeptide in health and disease. In: Incretins and Insulin Secretion. Vitamins and Hormones, Vol. 84, pp. 111-113 (ed. G. Litwack ), Oxford, Elsevier.
24. Chowers Y., Cahalon L., Lahav M. et al. (2000) Somatostatin through its specific receptor inhibits spontaneous and TNF-alpha and bacteria-induced IL-8 and IL-1b secretion from intestinal epithelial cells. J. Immunol. 165, 2955-2961.
25. Coleman N.S., Marciani L., Blackshaw E. et al. (2003) Effect of a novel 5-HT3 receptor agonist MKC-733 on upper gastrointestinal motility in humans. Aliment. Pharmacol. Ther. 18, 1039-1048.
26. Costedio M.M., Hyman N., Mawe G.M. (2007) Serotonin and its role in colonic function and in gastrointestinal disorders. Dis. Colon Rectum 50, 376-388.
27. Cristina M.L., Lehy T., Zeitoun C.R., Dufougheray F. (1978) Fine Structural classification and comparative distribution of endocrine cells in normal human large intestine. Gastroenterology 75, 20-28.
28. De Bruine A.P., Wiggers T., Beek C. et al. (1993) Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance. Int. J. Cancer 54, 765-771.
29. Dietrich M.O. & Horvath T.L. (2009) Feeding signals and brain circuitry. Eur. J. Neurosci. 30, 1688-1696.
30. Dreyfus C.F., Sherman D.L., Gershon M.D. (1977) Uptake of serotonin by intrinsic neurons of the myenteric plexus grown in organotypic tissue culture. Brain Res. 128, 109-123.
31. Drucker D.J. (2002) Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 122, 531-544.
32. Dunlop S.P., Coleman N.S., Blackshaw E. et al. (2005) Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 3, 349-357.
33. Elliott R.M., Morgan L.M., Tredger J.A., Deacon S., Wright J., Marks V. (1993) Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J. Endocrinol. 138, 159-166.
34. El-Salhy M., Suhr O., Danielsson A. (2002) Peptide YY in gastrointestinal disorders. Peptides 23, 397-402.
35. Ensinck J.W., Vogel R.E., Laschansky E.C., Francis B.H. (1990) Effect of ingested carbohydrate, fat, and protein on the release of somatostatin-28 in humans. Gastroenterology 98, 633-638.
36. Ensinck J.W., Baskin D.G., Vahl T.P. et al. (2002) Thrittene, homologous with somatostatin-28((1-13)), is a novel peptide in mammalian gut and circulation. Endocrinology 143, 2599-2609.
37. Ensinck J.W., Laschansky E.C., Vogel R.E., D'Alessio D.A. (2003) Effect of ingested nutrients on release of thrittene into the human circulation. J. Clin. Endocrinol. Metab. 88, 4798-4804.
38. Ferrara A., Zinner M.J., Jaffe B.M. (1987) Intraluminal release of serotonin, substance P, and gastrin in the canine small intestine. Dig. Dis. Sci. 32, 289-294.
39. Fiocca R., Rindi G., Capella C. et al. (1987) Glucagon, glicentin, proglucagon, PYY, PP and prop-icosapeptide immunoreactivities of rectal carcinoid tumours and related non-tumor cells. Regul. Pept. 17, 9-29.
40. Franklin I.K. & Wollheim C.B. (2004) GABA in the endocrine pancreas: its putative role as an islet cell paracrine-signalling molecule. J. Gen. Physiol. 123, 185-190.
41. Fukumoto S., Tatewaki M., Yamada T. et al. (2003) Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284, R1269-R1276.
42. Gameiro A., Reimann F., Habib A.M. et al. (2005) The neurotransmitters glycine and GABA stimulate glucagon-like peptide-1 release from the GLUTag cell line. J. Physiol. 569, 761-772.
43. Garfield A.S. & Heisler L.K. (2009) Pharmacological targeting of the serotonergic system for the treatment of obesity. J. Physiol. 587, 49-60.
44. Gershon M.D. & Tack J. (2007) The serotonin signalling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132, 397-414.
45. Ghatei M.A., Goodlad R.A., Taheri S. et al. (2002) Proglucagon-derived peptides in intestinal epithelial proliferation: glucagon-like peptide-2 is a major mediator of intestinal epithelial proliferation in rats. Dig. Dis. Sci. 46, 1255-1263.
46. Gordon J.I. (1993) Understanding gastrointestinal epithelial cell biology: lessons from mice with help from worms and flies. Gastroenterology 104, 315-324.
47. Gordon J.I. & Hermiston M.L. (1994) Differentiation and self-renewal in the mouse gastrointestinal epithelium. Curr. Opin. Cell Biol. 6, 795-803.
48. Grabowski P., Sturm I., Schelwies K. et al. (2006) Analysis of neuroendocrine differentiation and the p53/BAX pathway in UICC stage III colorectal carcinoma identifies patients with good prognosis. Int. J. Colorectal Dis. 21, 221-230.
49. Greeley G.H., Jeng Y.J., Gomez G. et al. (1989) Evidence for regulation of peptide-YY release by the proximal gut. Endocrinology 124, 1438-1443.
50. Grider J.R. (2003) Neurotransmitters mediating the intestinal peristaltic reflex in the mouse. J. Pharmacol. Exp. Ther. 307, 460-467.
51. Gulubova M. & Vlaykova T. (2008) Chromogranin A-, serotonin-, synaptophysin- and vascular endothelial growth factor-positive endocrine cells and the prognosis of colorectal cancer: an immunohistochemical and ultrastructural study. J. Gastroenterol. Hepatol. 23, 1574-1585.
52. Gustafsson B.I., Bakke I., Tommeras K., Waldrum H.L. (2006) A new method for visualisation of gut mucosal cells, describing the enterochromaffin cell in the rat gastrointestinal tract. Scand. J. Gastroenterol. 41, 390-395.
53. Hamada Y., Oishi A., Shoji T. et al. (1991) Endocrine cells and prognosis in patients with colorectal carcinoma. Cancer 69, 2641-2646.
54. Hasegawa H., Yanagisawa M., Inoue F., Yanaihara N., Ichiyama A. (1987) Demonstration of non-neural tryptophan 5-monooxygenase in mouse intestinal mucosa. Biochem. J. 248, 501-509.
55. Hasler W.L. (2009) Serotonin and the GI Tract. Curr. Gastroenterol. Rep. 11, 383-391.
56. Hauso O., Gustafsson B.I., Waldum H.L. (2007) Long slender cytoplasmic extensions: a common feature of neuroendocrine cells? J. Neuroendocrinol. 19, 739-742.
57. Ho S.B., Itzkowitz S.H., Friera A.M., Jiang S.-H., Kim Y.S. (1989) Cell lineage markers in premalignant and malignant colonic mucosa. Gastroenterology 97, 392-404.
58. Hocker M. & Wiedenmann B. (1998) Molecular mechanisms of enteroendocrine differentiation. Ann. N Y Acad. Sci. 859, 160-174.
59. Holbrook J.D., Gill C.H., Zebda N. et al. (2009) Characterisation of 5-HTc, 5-HT3d and 5-HT3e receptor subunits: evolution, distribution and function. J. Neurochem. 108, 384-396.
60. Holle G.E., Dietl J., Demir I. (2003) Influence of the intramural innervation on the morphogenesis of the enteroendocrine cells and genetic construct involved (review). Int. J. Mol. Med. 11, 275-285.
61. Holst J.J. (2007) The physiology of glucagon-like peptide 1. Physiol. Rev. 87, 1409-1439.
62. Holst J.J. & Gromada J. (2004) Role of incretin hormones in the regulation of insulin secretion in diabetic and non diabetic humans. Am. J. Physiol. Endocrinol. Metab. 287, E199-E206.
63. Hope N., Butt G., Ross I. et al. (2001) Somatostatin enhances cAMP-dependant short-circuit current in human colon via somatostain receptor subtype 2. Dig. Dis. Sci. 46, 2499-2503.
64. Jian R., Besterman H.S., Sarson D.L. et al. (1981) Colonic inhibition of gastric secretion in man. Dig. Dis. Sci. 26, 195-201.
65. Karaki S. & Kuwahara A. (2010) Roles of short-chain fatty acids and their receptors in colonic motility. Biosci. Microflora 29, 31-40.
66. Kellum J.M., Albuquerque F.C., Stoner M.C., Harris R.P. (1999) Stroking human jejunal mucosa induces 5-HT release and Cl- secretion via afferent neurons and 5HT4 receptors. Am. J. Physiol. 277, G515-G520.
67. Kidd M., Modlin I.M., Gustafsson B.I., Drozdov I., Hauso O., Pfragner R. (2008) Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants and olfactants. Am. J. Physiol. Gastrointest. Liver Physiol. 295, 260-272.
68. Kido T., Sumii K., Kawano M., Sumii M., Yoshihara M., Chayami K. (2003) Food deprivation enhances somatostatin and somatostatin receptor subtype expression in the rat colon. Regul. Pept. 114, 167-173.
69. Kim B.J., Carlson O.D., Jang H.J., Elahai D., Barry C., Egan J.M. (2005) Peptide YY is secreted after oral glucose administration in a gender-specific manner. J. Clin. Endocrinol. Metab. 90, 6665-6671.
70. Kloppel G. & Anlauf M. (2005) Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of the gastrointestinal tract. Best Pract. Res. Clin. Gastroenterol. 19, 507-517.
71. Kloppel G., Perren A., Hetz P.U. (2004) The gastroenteropancreatic neuroendocrine cell system and its tumors. The WHO classification. Ann. N Y Acad. Sci. 1014, 13-27.
72. Kuemmerle J.F., Kraus H., Kellum J.M. (1987) Serotonin release is mediated by muscarinic receptors on duodenal mucosal cells. J. Surg. Res. 43, 139-142.
73. Kuhn D.M., Meyer M.A., Lovenburg W. (1980) Comparisons of tryptophan hydroxylase from a malignant murine mast cell tumor rat mesencephalic tegmentum. Arch. Biochem. Biophys. 199, 355-361.
74. La Rosa S., Uccella S., Capella C., Chiaravalli A.M., Sessa F. (1998) Localization of acidic fibroblast growth factor, fibroblast growth factor receptor-4, transforming growth factor-alpha, and epidermal growth factor receptor in human endocrine cells of the gut and related tumours: an immunohistochemical study. Appl. Immunohistochem. Mol. Morphol. 6, 199-208.
75. Lloyd R.V., Schroeder G., Bauman M.D. et al. (1998) Prevalence and prognostic significance of neuroendocrine differentiation in colorectal carcinomas. Endocr. Pathol. 9, 35-42.
76. Lordal M., Wallen H., Hjemdahl P., Beck O., Hellstrom P.M. (1998) Concentration-dependent stimulation of intestinal phase III of migrating motor complex by circulating serotonin in humans. Clin. Sci. (Colch) 94, 663-670.
77. Low M.J. (2004) The somatostatin neuroendocrine system: physiology and clinical relevance in gastrointestinal and pancreatic disorders. Best Pract. Res. Clin. Endocrinol. Metab. 18, 607-622.
78. Lowell A.B., Strosberg J.R., Klimstra D.S. et al. (2010) The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (NETs). Well-differentiated NETs of the distal colon and rectum. Pancreas 39, 767-774.
79. Mannon P. (2002) Peptide YY as a growth factor for intestinal epithelium. Peptides 23, 383-388.
80. Mari A., Schmitz O., Gastaldelli A., Oestergaard T., Nyholm B., Ferrannini E. (2002) Meal and oral glucose tests for assessment of beta-cell function: modelling analysis in normal subjects. Am. J. Physiol. Endocrinol. Metab. 283, E1159-E1166.
81. Milutinovic A.S., Todorovic V., Milosavljevic T., Micev M., Spuran M., Drndarevic N. (2003) Somatostatin and D cells in patients with gastritis in the course of Helicobacter pylori eradication: a six-month, follow-up study. Eur. J. Gastroenterol. Hepatol. 15, 755-756.
82. Modlin I., Kidd M., Pfragner R., Eick G.N., Champaneria M.C. (2006) The functional characterization of normal and neoplastic human enterochromaffin cells. J. Clin. Endocrinol. Metab. 91, 2340-2348.
83. Mori M., Mimori K., Kamakura T., Adachi Y., Ikeda Y., Sugimachi K. (1995) Chromogranin positive cells in colorectal carcinoma and transitional mucosa. J. Clin. Pathol. 48, 754-758.
84. Mortensen K., Christensen L.L., Holst J.J., Orskov K. (2003) GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regul. Pept. 114, 189-196.
85. Naslund E., Gryback P., Backman L. et al. (1998) Distal small bowel hormones: correlation with fasting antroduodenal motility and gastric emptying. Dig. Dis. Sci. 43, 945-952.
86. Näslund E., Bogefors J., Skogar S. et al. (1999) GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans. Am. J. Physiol. 277(3 Pt 2), R910-R916.
87. Nilsson O., Bilchik A.J., Goldenring J.R., Ballantyne G.H., Adrian T.E., Modlin I.M. (1991) Distribution and immunocytochemical colocalization of peptide YY and enteroglucagon in endocrine cells of the gut. Endocrinology 129, 139-148.
88. Nitta Y., Nishibori M., Iwagaki H. et al. (2001) Changes in serotonin dynamics in the gastrointestinal tract of Colon-26 tumour-bearing mice: effects of cisplatin treatment. Nuanyn-Schiedeberg's Arch. Pharmacol. 364, 329-334.
89. Otani N., Sasaki I., Naito H. et al. (1994) Inhibitory effect of peptide YY, neurotensin and glicentin on upper gastrointestinal motility in dogs. Biomed. Res. 15, 299-302.
90. Patel Y.C., Wheatley T., Ning C. (1981) Multiple forms of immunoreactive somatostatin: comparison of distribution in neural and nonneural tissues and portal plasma of the rat. Endocrinology 109, 1943-1949.
91. Penman E., Wass J.A.H., Butler M.G. et al. (1987) Distribution and characterisation of immunoreactive somatostatin in human gastrointestinal tract. Reg. Peptides 7, 53-65.
92. Pironi L., Stanghellini V., Mignoli M. et al. (1993) Fat-induced ileal brake in humans: a dose-dependent phenomenon correlated to plasma level of peptide YY. Gastroenterology 105, 733-739.
93. Plaisancie P., Dumoulin V., Chayvialle J.A., Cuber J.C. (1995) Luminal glucagon-like peptide-1-(7-36) amide-releasing factors in the isolated vascularly perfused rat colon. J. Endocrinol. 145, 521-526.
94. Portela-Gomes G.M., Stridsberg M., Johansson H., Grimelius L. (1997) Complex co-localisation of chromogranins and neurohormones in the human gastrointestinal tract. J. Histochem. Cytochem. 45, 815-822.
95. Rehfeld J.F. (1998) The new biology of gastrointestinal hormones. Physiol. Rev. 78, 1087-1108.
96. Reichlin S. (1987) Secretion of somatostatin and its physiological effect. J. Lab. Clin. Med. 109, 320-326.
97. Reimann F., Ward P.S., Gribble F.M. (2006) Signaling mechanisms underlying the release of glucagon-like peptide 1. Diabetes 55 (Suppl. 2), S78-S85.
98. Reubi J.C. (2004) Somatostatin and other peptide receptors as tools for tumor diagnosis and treatment. Neuroendocrinology 80 (Suppl. 1), 51-56.
99. Rindi G., Leiter A.B., Kopin A.S., Bordi C., Solcia E. (2004) The "normal" endocrine cell of the gut. Changing concepts and new evidences. Ann. N Y Acad. Sci. 1014, 1-12.
100. Rindi G., Efrat S., Ghatei M.A., Bloom S.R., Solcia E., Polak J.M. (2007) Glucagonomas of transgenic mice express a wide range of general neuroendocrine markers and bioactive peptides. Virchows Arch. 419, 115-129.
101. Rinke A., Muller H.H., Schade-Brittinger C. et al. (2009) Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J. Clin. Oncol. 27, 4656-4663.
102. Roth K.A., Kim S., Gordon J.I. (1992) Immunocytochemical studies suggest two pathways for enteroendocrine cell differentiation in the colon. Am. J. Physiol. 263, G174-G180.
103. Rubin G., de Wit N., Meineche-Schmidt V., Seifert B., Hall N.P., Hungin A.P. (2005) Identification and diagnosis of patients with irritable bowel syndrome in primary care: nominal group technique. Gut 54, A3.
104. Rudnicki M., Kuvshinoff B.W., McFadden D.W. (1992) Extrinsic neural contribution to ileal peptide YY (PYY) release. J. Surg. Res. 52, 591-595.
105. Saclarides T.J., Szeluga D., Staren E.D. (1994) Neuroendocrine cancers of the colon and rectum: results of a ten year experience. Dis. Colon Rectum 37, 635-642.
106. Saras J., Gronberg M., Stridsberg M., Oberg K.E., Janson E.T. (2007) Somatostatin induces rapid contraction of neuroendocrine cells. FEBS Lett. 581, 1957-1962.
107. Schjoldager B., Mortensen P.E., Myhre J., Christiansen J., Holst J.J. (1989) Oxyntomodulin from the distal gut: role in the regulation of gastric and pancreatic functions. Dig. Dis. Sci. 34, 1411-1420.
108. Schmid K.W., Weiler R., Xu R.W., Hogue-Angeletti R., Fischer-Colbrie R., Winkler H. (1989) An immunological study on chromogranin A and B in human endocrine and nervous tissues. Histochem. J. 21, 365-373.
109. Schonhoff S.E., Giel-Moloney M., Leiter A. (2004) Minireview: development and differentiation of gut endocrine cells. Endocrinology 145, 2639-2644.
110. Seretis E.C., Agnantis N.J., Golematis V.C., Voloudakis-Balatzis I.E. (2004) Electron immunocytochemical demonstration of serotonin, vasoactive intestinal polypeptide, bombesin, somatostatin and glucagon in mirror biopsies from primary colorectal adenocarcinoma. J. Exp. Clin. Cancer Res. 23, 477-484.
111. Shamsuddin A.M., Phelps P.C., Trump B.F. (1982) Human large intestinal epithelium: light microscopy, histochemistry and ultrastructure. Human Pathol. 13, 790-803.
112. Sjolund K., Sanden G., Hakanson R., Sundler F. (1983) Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology 85, 1120-1130.
113. Smith D.M. & Haggitt R.C. (1984) The prevalence and prognostic significance of argyrophil cells in colorectal carcinomas. Am. J. Surg. Pathol. 8, 123-128.
114. Solcia E., Polak J.M., Pearse A.G.E. et al. (1978) Lausanne 1977 classification of gastroenteropancreatic endocrine cells. In: Gut Hormones, pp. 40-48 (ed. S.R. Bloom ), Edinburgh: Churchill Livingstone.
115. Solcia E., Capella C., Fiocca R., Sessa F., La Rosa S., Rindi G. (1998) Disorders of the Endocrine System. In: Pathology of the Gastrointestinal Tract, pp. 295-322 (eds S.C. Ming & H. Goldman ), Philadelphia, PA: Williams & Wilkins.
116. Spiller R. (2008) Serotonin and GI clinical disorders. Neuropharmacology 55, 1072-1080.
117. Stanisz A.M., Befus D., Bienenstock J. (1986) Differential effects of vasoactive intestinal polypeptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J. Immunol. 136, 152-156.
118. Sternini C., Anselm L., Rozengurt E. (2008) Enteroendocrine cells: a site of 'taste' in gastrointestinal chemosensing. Curr. Opin. Endocrinol. Diabetes Obes. 15, 73-78.
119. Swatek J. & Chibowski D. (2000) Endocrine cells in colorectal carcinomas. Immunohistochemical study. Pol. J. Pathol. 51, 127-136.
120. Tang-Christensen M., Vrang N., Larsen P.J. (1998) Glucagon-like peptide 1 (7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment. Diabetes 47, 530-537.
121. Tolessa T., Gutniak M., Holst J.J., Efendic S., Hellstrom P.M. (1998) Glucagon-like peptide 1 retards gastric emptying and small bowel transit in the rat: effect mediated through central or enteric nervous mechanism. Dig. Dis. Sci. 43, 2284-2290.
122. Tonini M. (2005): 5-Hydroxytryptamine effect in the gut: the 3, 4 and 7 receptors. Neurogastroenterol. Motil. 17, 637-642.
123. Tsai C.-H., Hill M., Asa S.L., Brubaker P.L., Drucker D.J. (1997) Intestinal growth-promoting properties of glucagon-like peptide 2 in mice. Am. J. Physiol. 273, E77-E84.
124. Uehara S., Jung S., Morimoto R. et al. (2006) Vesicular storage and secretion of l-glutamate from glucagon-like peptide 1-secreting clonal intestinal L cells. J. Neurochem. 96, 550-560.
125. Van Lelyveld N., Ter Linde J., Schipper M.E., Samsom M. (2007) Regional differences in expression of TPH-1, SERT, 5-HT3, and 5-HT4 receptors in the human stomach and duodenum. Neurogastroenterol. Motil. 19, 342-348.
126. Varndell I.M., Lloyd R.V., Wilson B.S., Polak J.M. (1985) Ultrastructural localization of chromogranin: a potential marker for the electron microscopical recognition of endocrine cell secretory granules. Histochem. J. 17, 981-992.
127. Verdich C., Flint A., Gutzwiller J.-P. et al. (2001) A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J. Clin. Endocrinol. Metab. 86, 4382-4389.
128. ATP channel independent. Am. J. Physiol. Endocrinol. Metab. 284, E988-E1000.
129. Wang H., Steeds J., Motomura Y. et al. (2007) CD4+ T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection. Gut 56, 949-957.
130. Washington M.K., Tang L.H., Berlin J. et al. (2010) Protocol for the examination of specimens from patients with neuroendocrine tumours (carcinoid tumours) of the colon and rectum. Arch. Pathol. Lab. Med. 134, 176-180.
131. Watanabe T., Kubota Y., Sawada T., Muto T. (1992) Distribution and quantification of somatostatin in inflammatory disease. Dis. Colon Rectum 35, 488-494.
132. Weidenmann B., Frank W.W., Kuhn C., Moll R., Gould V.E. (1986) Synaptophysin: a novel marker protein for neuroendocrine cells and neoplasms. Proc. Natl Acad. Sci. USA 83, 3500-3504.
133. Weihe E. & Eiden L.E. (2000) Chemical neuroanatomy of the vesicular amine transporters. FASEB J. 14, 2435-2449.
134. Wettergren A., Scjoldager B., Mortensen P.E., Myhre J., Christiansen J., Holst J.J. (1993) Truncated GLP-1 (Proglucagon 78-107-Amide) inhibits gastric and pancreatic functions in man. Dig. Dis. Sci. 38, 665-673.
135. Wettergren A., Maina P., Boesby S., Holst J.J. (1997) Glucagon-like peptide-1 7-36 amide and peptide YY have additive inhibitory effect on gastric acid secretion in man. Scand. J. Gastroenterol. 32, 552-555.
136. Yeung T.M., Gandhi S.C., Wilding J.L., Muschel R., Bodmer W.F. (2010) Cancer stem cells from colorectal cancer-derived cell lines. Proc. Natl Acad. Sci. USA 107, 3722-3727.
137. Yu P.L., Okumiya K., Kinoshita M., Hasegawa H., Fujimiya M. (1999) Immunohistochemical localization of tryptophan hydroxylase in the human and rat gastrointestinal tracts. J. Comp. Neurol. 411, 654-665.
138. Zhang T., Brubaker P.L., Thompson J.C., Greeley Jr G.H. (1993) Characterization of peptide-YY release in response to intracolonic infusion of amino acids. Endocrinology 132, 553-557.